Company: INVUP
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001193
Chunk: 319

Company: Investview, Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 9
Chunk 319
---
 options as part of a compensation package offered to a new officer of the Company, and 5,000,000 stock options as part of the purchase
of the business and assets of Renu Laboratories, Inc. The options vest in equal amounts over a five-year period, at an exercise price
of $0.05 per share, with a seven-year life. We utilized the Black Scholes Model to value these options, and the expense related to these
options is being recognized over the vesting term. Also, during the year ended December 31, 2024, we cancelled 15,000,000 unvested options
and 10,000,000 vested options expired upon the resignation of an officer of the Company.

Transactions
involving our options are summarized as follows:

 SCHEDULE OF OPTIONS ACTIVITY

    Weighted 

    Average 

    Weighted  
    Grant-Date 

    Number of  
    Average  
    Per Share 

    Options  
    Exercise
    Price  
    Fair
    Value 
  
    Options outstanding
    at December 31, 2023 
     360,416,665  
    $0.05  
    $0.03 
  
    Granted 
     16,000,000  
    $0.05  
    $0.01 
  
    Canceled/Expired 
     (25,000,000) 
    $0.05  
    $0.03 
  
    Exercised 
     -  
    $-  
    $- 
  
    Options
    outstanding at December 31, 2024 
     351,416,665  
    $0.05  
    $0.03 

Details
of our options outstanding as of December 31, 2024, is as follows:

 SCHEDULE OF OPTIONS OUTSTANDING

    Options
    Exercisable  
    Weighted
    Average Exercise Price of Options Exercisable  
    Weighted
    Average Contractual Life of Options Exercisable (Years)  
    Weighted
    Average Contractual Life of Options Outstanding (Years) 
  
     183,291,665  
     0.05  
     4.48  
     4.62 

    F-19

INVESTVIEW,
INC.

NOTES
TO CONSOLIDATED FINANCIAL